<DOC>
	<DOCNO>NCT02556593</DOCNO>
	<brief_summary>This study ass efficacy IMRT combine erlotinib compare whole-brain radiotherapy EGFR wild type non-small cell lung cancer 4-10 brain metastasis .</brief_summary>
	<brief_title>IMRT Combined With Erlotinib EGFR Wild Type Non-small Cell Lung Cancer With 4-10 Brain Metastases</brief_title>
	<detailed_description>This study ass efficacy IMRT combine erlotinib compare whole-brain radiotherapy EGFR wild type non-small cell lung cancer 4-10 brain metastasis . All patient recruit randomly assign two group . Patients experimental group receive daily IMRT 45 Gy 15 fraction brain metastasis , combine daily erlotinib 150mg three week . Patients control group receive daily whole-brain radiotherapy 30 Gy 10 fraction .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Erlotinib Hydrochloride</mesh_term>
	<criteria>Pathologically confirm NSCLC wild type EGFR 410 brain metastasis high quality CT scan MRI . No previous EGFRTKI treatment . No previous brain radiotherapy . More 4 week last chemotherapy . Expected Survival least 2 month . KPS≥ 70 RTOG RPA performance status 01 Lab test meet criterion : White blood cell count ≥3×10^9 /L ; Platelet count≥100×10^9 /L ; Total bilirubin 1.5 time less upper limit normal ( ULN ) ; AST ALT 1.5 time less ULN ; Serum creatinine 1.5 time less ULN creatinine clearance rate ( CCR ) great equal 60 ml/min . Pregnancy test ( ) Be able sign inform consent form . With unstable systematical disease ( conclude acute infection , grade 4 hypertension , unstable angina pectoris , congestive heart failure , hepatopathy , nephropathy , metabolic disease ) With metastasis meninges . Taking antiepileptic ( phenytoin sodium etc . ) time Unable oral medication . Previous recent another malignancy , except nonmelanoma skin cancer cervical cancer situ</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Non-Small Cell Lung Cancer</keyword>
	<keyword>IMRT</keyword>
	<keyword>erlotinib</keyword>
	<keyword>whole-brain radiotherapy</keyword>
</DOC>